Shares of Cronos Group Inc. shot up 14% in very active afternoon trade Monday, paring earlier gains of as much as 30%, after Reuters reported that Altria Group Inc. MO, -0.01% was in early talks to buy the Canada-based cannabis company. Volume topped reached…
In case you aren’t aware of it already, let me be the first to tell you: There’s a battle brewing over marijuana north of the U.S. border, and the winning prize may be billions of dollars in revenue. Canada already…
Tilray (NASDAQ:TLRY) made a lot of early investors rich this year, but now that it’s a $10.6 billion company, further gains won’t be so easy to come by. In fact, buying the stock at the moment is an extremely risky bet. Tilray…
The marijuana industry has put on a show for pot enthusiasts and investors this year. The highlight, as you can imagine, was the legalization of recreational cannabis on Oct. 17 in Canada. In a few years, after the industry has had time…
Investors who bought MedMen Enterprises (NASDAQOTH:MMNFF) in recent months have been scratching their heads lately. Since legalized recreational marijuana sales began in Canada, the stock has fallen around 48% despite midterm election results in the U.S. that will expand state-legalized sales in MedMen’s…
Legal recreational marijuana sales in Canada haven’t had the effect on stock prices that investors had been hoping for. Shares of CannTrust Holdings (NASDAQOTH:CNTTF) and Aurora Cannabis (NYSE:ACB) have tumbled 37% and 44%, respectively since the rollout began, and careful shoppers are wondering which is a…
